When many companies talk about intellectual property (IP) for going global, their immediate response is, “We need to file more overseas patents as soon as possible.” However, for many technology-driven enterprises, patents alone are far from sufficient. What is truly needed is to integrate patents, Freedom-to-Operate (FTO) analyses, trade secrets, contractual arrangements, and risk control into a cohesive framework aligned with your commercialization pathway.

In recent years, Chinese companies have accelerated their global expansion, particularly in technology-intensive sectors such as new energy, batteries, energy storage, intelligent manufacturing, medical devices, and electronic hardware. When discussing IP with these companies, many react similarly: “Then we should quickly file more patents in the U.S. and Europe.” While this sounds reasonable, if you equate overseas IP work with merely “filing more overseas patents,” you are likely missing the bigger picture.

Why? Because the challenges encountered when going global extend far beyond the single dimension of “whether I own a patent.” For many technology-driven companies, the key questions you need to consider are:

•   How should I protect my core technology? Should I pursue patent protection or maintain it as a trade secret?

•   When I launch my products into overseas markets, will I infringe upon others' patent rights?

•   When sending samples, engaging in joint development, or supplying to overseas customers, how do I define the technical boundaries?

•   If a dispute arises later, have I established adequate defenses in advance?

Therefore, overseas IP is not essentially about “registering a few overseas patents.” Instead, it is about building a framework of protection and risk control around your business operations. Let's break this down.

1. Why is “filing a few overseas patents” far from enough?

In the early stages of going global, most companies first think of building an overseas patent portfolio—filing a batch in the U.S., a batch in Europe, or first taking a position via the Patent Cooperation Treaty (PCT). This step is certainly necessary.

But what truly determines whether your global expansion proceeds smoothly and your business remains stable are several other factors.

Owning patents does not equate to safety.

Many technology-driven companies operate under a mindset: “I developed this technology myself, and I have patent protection, so I should be safe.” Not necessarily. Owning your own patents merely means you have rights to a particular technical solution. It does not mean that practicing your product will not fall within the scope of others' patent protection. Many technology-intensive industries inherently have high patent density, long technology chains, and significant overlap between upstream and downstream players. Without careful attention, you may inadvertently step into a minefield that others laid out long ago.

Thus, you must not only consider “how to file for my technology,” but also simultaneously assess, “when I sell my product overseas, is there an infringement risk?”

Real risks often emerge during collaboration and implementation phases.

Many companies do not immediately sell products in large volumes overseas. Instead, they go through a series of preliminary steps: sending samples to customers, conducting tests and validation, providing technical solutions, discussing joint development, negotiating exclusive partnerships, and performing customized development.

It is precisely during these stages that technology is most likely to “leak beyond boundaries,” and legal risks are most likely to accumulate quietly.

Here are a few common pitfalls: technical information is sent out before a non-disclosure agreement (NDA) is properly executed; during sample testing, the other party obtains technical information beyond the necessary scope; in joint development, ownership of new achievements is unclear; during exclusive cooperation discussions, the exclusivity scope, territorial scope, and ownership of improvements are all ambiguous.

If these issues are not addressed early on, they can lead to considerable disputes later.

The deeper you go overseas, the less IP remains a standalone issue.

Especially when entering the U.S. market, IP issues rarely arise in isolation. They tend to intertwine with contractual terms, trade secrets, supply chain compliance, customs issues, Section 337 investigations, cease-and-desist letters and litigation, export controls, data compliance, and more.

What companies need to do is not simply “file patents,” but to establish a systematic framework capable of supporting overseas operations.

2. Overseas IP, in essence, comes down to three things

To put it directly, the IP work for companies going global revolves around three core tasks.

First: Protect your own technology.

First, determine: which technologies are suitable for patent protection? Which are better kept as trade secrets? Which technologies—though not the core—are still valuable for customer collaboration, financing, and negotiations, and thus worth securing?

Not all technologies are suitable for the “disclosure in exchange for exclusive rights” model. Process parameters, manufacturing details, formula know-how, debugging experience, internal test data—these types of information, once disclosed, may actually weaken your competitive advantage. Therefore, a better approach is usually not to file patents for everything, but to adopt a layered protection strategy.

Second: Align IP work with your business rhythm.

IP cannot be handled in isolation from business operations. You need to assess: which overseas market is the top priority in the next 12 to 24 months? Which product line will be commercialized first? What are key customers concerned about? Is your current cooperation model based on selling goods, testing, joint development, or licensing?

These questions directly determine which markets are worth seeking patent protection in first, which products require FTO analyses first, which contract templates need to be prepared, and which technical disclosure processes need to be established.

IP must follow your global expansion rhythm.

Third: Front-load legal and risk control measures.

Many companies think that legal issues are something you “call a lawyer for when a problem arises.” But in overseas business, the most valuable legal support happens before anything goes wrong.

Why? Because many risks, if left until later, carry entirely different costs. You have already launched a product before realizing you might be infringing someone's patent. You have already started a collaboration before discovering that ownership of improvements was never agreed upon. You have already sent technical materials before realizing that confidentiality boundaries were too vague. You have already deepened a customer relationship before starting to formalize contracts. Doing these things early is merely process design; doing them late turns into dispute resolution and can directly impact your business.

3. A complete overseas IP framework typically includes five components

For many technology-driven companies planning to go global, a relatively complete IP and legal support framework can generally be broken down into five modules.

1) Core patent portfolio: focus on structure, not quantity.

The key to overseas patents is never “how many were filed,” but whether the portfolio structure is sound.

A practically valuable portfolio strategy typically considers not just the number of applications, but whether the patent combination aligns with your technology roadmap, product structure, manufacturing processes, application scenarios, and commercial collaboration goals. A common layered approach includes: a foundational layer covering core platforms or basic technological routes; a second layer covering manufacturing processes and process optimization; a third layer covering specific products and application scenarios; and a fourth layer covering defensive or transactional patents useful for customer collaboration, financing, licensing, and negotiations.

Such a structure aligns with business competition, rather than merely creating an impression of “many patents.”

2) FTO and competitor landscape: a “minefield map” before going global.

Many companies know they should conduct FTO analyses, but their understanding of them is often vague.

The core value of an FTO analysis is not to provide an “absolute safety” guarantee—no one can give that. Rather, it helps you see in advance: which technical points carry high risk, which competitors require close monitoring, where you can design around existing patents, and which issues could affect customer adoption and market entry.

From a business perspective, an FTO analysis is a minefield map. It is not meant to stop you from moving forward, but to show you where to detour, where to slow down, and where to prepare contingency plans.

3) Trade secret protection: the most overlooked vulnerability.

Compared to patents, trade secrets are far too easily neglected by companies.

Yet in many technology-intensive industries, the truly valuable competitive advantages often lie in process parameters, formula details, manufacturing processes, debugging experience, internal test data, mass production optimization methods, and similar information. Such information may not be suitable for patent disclosure, but is extremely worth protecting as trade secrets.

The problem is that many companies talk about confidentiality but operate rather loosely: sending materials without control, poor version management, allowing any employee to access core documents, lacking approval processes for external disclosure, and failing to maintain proper records and evidence trails.

Trade secret protection is not completed by signing an NDA alone. It requires a system that includes document classification, disclosure authorization, approval workflows, access logs, and evidence retention mechanisms. If this part is handled poorly, you will be very vulnerable later.

4) Contract and transaction structure design: determines whether disputes will erupt.

For many technology-driven companies, overseas cooperation is not simply selling goods. In scenarios involving sample testing, joint validation, co-development, exclusive partnerships, technology licensing, territorial authorization, and customized development, the most problematic terms often cluster around these areas:

Ownership of pre-existing technology (background IP)

Ownership of new achievements generated during cooperation (foreground IP)

Ownership of improvements

The scope of the other party's rights to use the results

Whether the cooperation is exclusive

Handling of materials and samples after termination

Rights to continue using relevant achievements if negotiations break down

These clauses may seem “legalistic,” but they directly determine whether you will be exposed to future claims.

However, there is another equally important and often overlooked source of risk: The assessment of the partner itself.

Choosing a partner is essentially choosing business risk. No matter how tightly you draft your clauses, if the partner has underlying credit or performance issues, the risk remains uncontrollable. Therefore, before entering into cooperation, conducting necessary due diligence on the partner is critical. This includes examining the partner's credit status, history of disputes or litigation (including public judgments, arbitrations, and negative public records), information on beneficial owners and related parties, and their actual ability and willingness to perform payment obligations.

Often, the problem does not arise from a poorly written contract, but from choosing the wrong partner from the outset. Front-loading due diligence is essentially a way to “see the other party clearly before the marriage” and block risks before they enter the relationship.

5) Compliance and dispute contingency planning: not something to think about after a problem arises.

As companies penetrate deeper into overseas markets, risks extend beyond patent infringement. Responding to cease-and-desist letters, customs issues, Section 337 investigations, export controls, data and cross-border compliance, litigation, and administrative disputes—all of these can arise.

This does not mean you need to implement the highest level of risk management for all risks from day one. But you should at least have a basic assessment: which risks should you prioritize? Which markets carry higher risks? Which product lines are more sensitive? With this foundation, you will not be completely passive when facing customers, investors, partners, or disputes.

4. The most common pitfalls

Based on extensive interaction with companies, several pitfalls appear frequently.

Pitfall 1: Filing a bunch of patents first. The problem is not with the act of filing itself, but with the lack of prioritization and alignment with business needs. The result is that you spend a lot of money and file many applications, but only a few actually hold business value or support implementation.

Pitfall 2: Only looking at whether you have patents, not whether others do. Technology-driven companies are especially prone to this mistake. However, the risk of market entry often comes precisely from patent networks that others laid down long ago. Protecting yourself and clearing others' rights must be done simultaneously.

Pitfall 3: Relying solely on NDAs for confidentiality. NDAs are important, but they only solve paper-level problems. Without internal classification, approval processes, access logs, and permission controls, an NDA alone cannot hold up.

Pitfall 4: Starting cooperation first and adding contracts later. This is the most dangerous habit. Especially in scenarios involving sample testing, joint development, improvement ownership, and exclusive cooperation, many risks arise during the “let's do it first and talk later” phase.

5. Four self-check questions you can do right away

If your company is preparing to go global or is already engaging with overseas customers, start by asking yourself these four questions:

Which overseas market is the top priority in the next 12 to 24 months? Market priority determines the order of patent portfolio development and risk assessment.

Which product line will be commercialized first? Not all products require the same initial depth of IP work; focus on those closest to launch.

Have you organized your existing patents and public disclosures by product line or technology module? Without this step, much of the follow-up work will be chaotic.

Are you already sending samples, testing, engaging in joint development, or negotiating exclusive cooperation? If yes, then much of the legal and IP work can no longer wait.

Concord & Sage Commentary:

For many technology-driven companies, going global is by no means something that “filing a few more overseas patents” can solve.

What truly determines whether you can build a stable, long-term, and defensible overseas business is the integrated combination of patent portfolio strategy, FTO analyses, trade secret protection, contract and transaction structuring, and compliance and dispute contingency planning.

These tasks may seem disparate, but they all point to the same question: Can you build a cohesive framework around your commercialization pathway that integrates protection, implementation, and risk control?

The core of overseas IP is about doing things right, not doing many things. Prioritize your key markets, key products, and key cooperation models, get the sequence correct, and secure the critical nodes—that is where your investment truly counts.